Implantable 'Biohybrid Organ' aims to control severe diabetes
NCT ID NCT03513939
Summary
This study is testing a small, implantable device called the Cell Pouch that holds insulin-producing cells for people with severe Type 1 diabetes. The goal is to see if this 'biohybrid organ' is safe and can help reduce dangerous low blood sugar episodes and improve blood sugar control. Participants must take lifelong immunosuppressant drugs to prevent their bodies from rejecting the implanted cells.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 1 DIABETES MELLITUS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
University of Chicago Medical Center
Chicago, Illinois, 60637, United States
Conditions
Explore the condition pages connected to this study.